Abstract
Merkel cell carcinomas (MCCs) are derived from the mechanoreceptor cells located in the basal layer of the epidermis and are considered a primary cutaneous neuroendocrine malignancy with characteristically small, round blue cells seen on microscopy [1]. MCC is uncommon, but the incidence is rising and markedly increased in immunosuppressed patients. Chronic sun exposure is presumed to be the chief aetiological factor but, more recently, emerging evidence suggests that merkel cell polyomavirus may also contribute to its development [2]. MCC is considered an aggressive skin malignancy in most patients, with a propensity to locoregional and distant relapse.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Mendenhall WM, Kirwan JM, Morris CG, et al. Cutaneous Merkel cell carcinoma. Am J Otololaryngol Head Neck Med Surg. 2012;33:88–92.
Amber K, McLeod MP, Nouri K. The Merkel cell polyomavirus and its involvement in Merkel cell carcinoma. Dermatol Surg. 2013;39:232–8.
Howle J, Veness M. Sentinel lymph node biopsy in patients with Merkel cell carcinoma: an emerging role and the Westmead hospital experience. Australas J Dermatol. 2012;53:26–31.
Foote M, Veness M, Zarate D, et al. Merkel cell carcinoma: the prognostic implications of an occult primary in stage 3B (nodal) disease. J Am Acad Dermatol. 2012;67:395–9.
Concannon R, Larcos GS, Veness M. The impact of 18FDG PET/CT scanning for staging and management of Merkel cell carcinoma: results from Westmead hospital, Sydney, Australia. J Am Acad Dermatol. 2010;62:76–84.
Fields RC, Busan KJ, Chou JF, et al. Five hundred patients with Merkel cell carcinoma evaluated at a single institution. Ann Surg. 2011;254:465–75.
Howle J, Hughes M, Gebski V, et al. Merkel cell carcinoma: an Australian perspective and the importance of addressing the regional lymph nodes in clinically node negative patients. J Am Acad Dermatol. 2012;67:33–40.
Lemos BD, Storer BE, Iyer JG, et al. Pathological nodal evaluation improves prognostic accuracy in Merkel cell carcinoma: analysis of 5823 cases as the basis of the first consensus staging system. J Am Acad Dermatol. 2010;63:751–61.
Veness M, Foote M, Gebski V, et al. The role of radiotherapy alone in patients with Merkel cell carcinoma: reporting the australian experience of 43 patients. Int J Radiat Oncol Biol Phys. 2010;78:703–9.
Poulsen M, Rischin D, Porter I, et al. Does chemotherapy improve survival in high-risk stage 1 and 2 Merkel cell carcinoma of the skin? Int J Radiat Oncol Biol Phys. 2006;64:114–9.
Poulsen M, Rischin D, Walpole E, et al. High-risk Merkel cell carcinoma of the skin treated with synchronous carboplatinum/etoposide and radiation: a Trans Tasman Radiation Oncology Group Study-TROG 96:07. J Clin Oncol. 2003;21:4371–6.
Alsaad K, Obaidat N, Ghazarian D. Skin adnexal neoplasms-part 1: an approach to tumours of the pilosebaceous unit. J Clin Pathol. 2007;60:129–44.
Obaidat N, Alsaad K, Ghazarain D. Skin adnexal neoplasms-part 2: an approach to tumours of cutaneous sweat glands. J Clin Pathol. 2007;60:145–59.
Brown C, Dy L. Eccrine porocarcinoma. Dermatol Ther. 2008;21:433–8.
Yu J, Patel S, Decker R, Wilson L. Surveillance, Epidemiology and End Results (SEER) database analysis of microcystic adnexal carcinoma (sclerosing sweat duct carcinoma) of the skin. Am J Clin Oncol. 2010;33:125–7.
Baxi S, Deb S, Weedon D, et al. Microcystic adnexal carcinoma of the skin: the role of adjuvant radiotherapy. J Med Imaging Radiat Oncol. 2010;54:477–82.
Dasgupta T, Wilson L, Yu J. A retrospective review of 134 cases of sebaceous carcinoma. Cancer. 2009;115:158–65.
Erovic BM, Goldstein DP, Kim D, et al. Sebaceous gland carcinoma of the head and neck: the Princess Margaret Hospital experience. Head Neck. 2013;35:316–20.
Miyamoto T, Haggari Y, Inoue S, et al. Axillary apocrine carcinoma with benign apocrine tumours: a case report involving a pathological and immunohistochemical study and review of the literature. J Clin Pathol. 2005;58:757–61.
Robson A, Lazar A, Nagi B, et al. Primary cutaneous apocrine carcinoma: a clinico-pathologic analysis of 24 cases. Am J Surg Pathol. 2008;32:682–90.
Ming H, Jih M, Friedman P, et al. A rare case of fatal primary cutaneous mucinous carcinoma of the scalp with multiple in-transit and pulmonary metastases. J Am Acad Dermatol. 2005;52:S76–80.
Naylor E, Sarkar P, Perlis C, et al. Primary cutaneous adenoid cystic carcinoma. J Am Acad Dermatol. 2008;58:636–41.
Dores G, Huycke M, Devesa S, et al. Primary cutaneous adenoid cystic carcinoma in the United States: incidence, survival, and associated cancers 1976 to 2005. J Am Acad Dermatol. 2010;63:71–8.
Robson A, Greene J, Ansari N, et al. Eccrine porocarcinoma (malignant eccrine poroma): a clinic-pathologic study of 69 cases. Am J Surg Pathol. 2001;25:710–20.
Clinical Practice Guide: Basal cell carcinoma, squamous cell carcinoma (and related lesions)–a guide to clinical management in Australia. Sydney: Cancer Council Australia and Australian Cancer Network; 2008. Available at: http://www.cancer.org.au/content/pdf/HealthProfessionals/ClinicalGuidelines/Basal_cell_carcinoma_Squamous_cell_carcinoma_Guide_Nov_2008-Final_with_Corrigendums.pdf
Gulleth Y, Goldberg N, Silverman RP, et al. What is the best surgical margin for a basal cell carcinoma: a meta-analysis of the literature. Plast Reconstr Surg. 2010;126:1222–31.
Mosterd K, Krekels G, Nieman F, et al. Surgical excision versus Mohs’ micrographic surgery for primary and recurrent basal cell carcinoma of the face: a prospective randomised-controlled trial with 5-years follow-up. Lancet Oncol. 2008;9:1149–56.
Beth-Hextall FJ, Perkins W, Bong J, et al. Interventions for basal cell carcinoma of the skin. Cochrane Database Syst Rev. 2007;(1):CD003412.
Veness MJ. The important role of radiotherapy in patients with non-melanoma skin cancer and other cutaneous entities. J Med Imaging Radiat Oncol. 2008;52:278–86.
Palmer VM, Wilson PR. Incompletely excised basal cell carcinoma: residual rates at Moh’s surgery. Dermatol Surg. 2013;39:706–18.
Chan S, Dhadda AS, Swindell R. Single fraction radiotherapy for small superficial carcinoma of the skin. Clin Oncol. 2007;19:256–9.
Geisse J, Caro I, Lindholm J, et al. Imiquimod 5 % cream for the treatment of superficial basal cell carcinoma: results from two phase III, randomized, vehicle-controlled studies. J Am Acad Dermatol. 2004;50:722–33.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Faruque Riffat, Carsten E. Palme, Michael Veness, Rehan Kazi, Raghav C. Dwivedi
About this chapter
Cite this chapter
Veness, M., Howle, J. (2015). Merkel Cell Carcinoma, Adnexal Carcinoma and Basal Cell Carcinoma. In: Riffat, F., Palme, C., Veness, M. (eds) Non-melanoma Skin Cancer of the Head and Neck. Head and Neck Cancer Clinics. Springer, New Delhi. https://doi.org/10.1007/978-81-322-2497-6_6
Download citation
DOI: https://doi.org/10.1007/978-81-322-2497-6_6
Publisher Name: Springer, New Delhi
Print ISBN: 978-81-322-2496-9
Online ISBN: 978-81-322-2497-6
eBook Packages: MedicineMedicine (R0)